Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Diclofenac Sodium Gel in Knee Osteoarthritis
NCT02913521Phase 3Completed
- Sponsor
- Akorn
- Start
- Jun 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in osteoarthritis (OA) (3 arms), sponsored by Akorn. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index Pain Scale at 8 weeks. Started Jun 2015; status: completed.
02
Drugs
diclofenac
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02913521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02913521.